| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |